Brain metastases in patients with oncogenic-driven non-small cell lung cancer: Pros and cons for early radiotherapy-Reference-Cited by-同舟云学术

Brain metastases in patients with oncogenic-driven non-small cell lung cancer: Pros and cons for early radiotherapy

Published:2021-11 Issue: Volume:100 Page:102291
ISSN:0305-7372
Container-title:Cancer Treatment Reviews
language:en
Short-container-title:Cancer Treatment Reviews

Author:

Lee Jiyun,Ahn Myung-Ju

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Reference73 articles.

1. Non-small-cell Lung Cancer With Brain Metastasis at Presentation;Waqar;Clin Lung Cancer.,2018

2. Brain metastases in oncogene-driven non-small cell lung cancer;Nishino;Transl Lung Cancer Res.,2019

3. Lifetime Occurrence of Brain Metastases Arising from Lung, Breast, and Skin Cancers in the Elderly: A SEER-Medicare Study;Ascha;Cancer Epidemiol Biomarkers Prev.,2019

4. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology. Non-Small Cell Lung Cancer. Version 4. 2021 - March 3, 2021. [accessed on 25 May 2021].

5. Second ESMO consensus conference on lung cancer: pathology and molecular biomarkers for non-small-cell lung cancer;Kerr;Ann Oncol.,2014

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Local control strategies for management of NSCLC with oligoprogressive disease;Cancer Treatment Reviews;2023-11

2. Modern Stereotactic Radiotherapy for Brain Metastases from Lung Cancer: Current Trends and Future Perspectives Based on Integrated Translational Approaches;Cancers;2023-09-18

3. A multifunctional metal-organic framework nanosystem disrupts redox homeostasis for synergistic therapy;Journal of Colloid and Interface Science;2023-09

4. Central nervous system efficacy of rezivertinib (BPI-7711) in advanced NSCLC patients with EGFR T790M mutation: A pooled analysis of two clinical studies;Lung Cancer;2023-06

5. Experimental study of EGFR-TKI aumolertinib combined with ionizing radiation in EGFR mutated NSCLC brain metastases tumor;European Journal of Pharmacology;2023-04